Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
009: FIELD MONITORING OF THE Z BENEFITS FOR BREAST CANCER OF THE PHILIPPINE HEALTH INSURANCE CORPORATIONReyes, Merla Rose D ; Santillan, Melanie C ; Tacang, Aristides L ; Vecina, Gemma S ; Daryl Ruviro C Calabio ; Lanuza, Arhur M ; Soria, Francisco Z ; Lavina, Shiela Marie SBMJ open, 2015-01, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.9 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
2 |
Material Type: Artigo
|
0142 Training in safe administration of intrathecal chemotherapy – is in situ simulation the answer?: A pilot studyPrakash, Anoop ; Farooq, Omer ; Durairaj, Senthilkumar ; Allsup, David ; Purva, MakaniBMJ simulation & technology enhanced learning, 2015-11, Vol.1 (Suppl 2), p.A56 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
3 |
Material Type: Artigo
|
014 Intra-arterial chemotherapy (chemosurgery) in the ophthalmic artery for the treatment of retinoblastoma in children: 3 year experienceGobin, P ; Marr, B ; Dunkel, I ; Brodie, S ; Abramson, DJournal of neurointerventional surgery, 2009-07, Vol.1 (1), p.77-78 [Periódico revisado por pares]BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
02 First-line palliative chemotherapy for esophageal and gastric cancer: practice patterns and outcomes in the general population. S. Merchant , C. BoothCanadian journal of surgery, 2021-11, Vol.64 (6), p.137 [Periódico revisado por pares]CMA Joule IncTexto completo disponível |
|
5 |
Material Type: Artigo
|
02 First-line palliative chemotherapy for esophageal and gastric cancer: practice patterns and outcomes in the general population. S. Merchant (Queen's University, Kingston, Ont.), W. Kong (Queen's Cancer Research Institute, Kingston, Ont.), B. Gyawali (Queen's University, Kingston, Ont.), T. Hanna (Queen's University, Kingston, Ont.), W. Chung (Queen's University, Kingston, Ont.), S. Nanji (Queen's University, Kingston, Ont.), S. Patel (Queen's University, Kingston, Ont.), C. BoothCanadian journal of surgery, 2021-11, Vol.64 (6), p.137 [Periódico revisado por pares]CMA Joule IncTexto completo disponível |
|
6 |
Material Type: Artigo
|
0351: Concurrent Chemoradiotherapy in Patients with Cervical Carcinoma: Our Institutional ExperienceSharma, D N ; Rath, G K ; Julka, P KInternational journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.700-700 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
7 |
Material Type: Artigo
|
0372: The Clinical Values of Squamous Cell Carcinoma Antigen and Carcinoembryonic Antigen in Patients with Cervical Cancer Treated with Concurrent ChemoradiotherapyYoon, S M ; Shin, K H ; Kim, J ; Yoo, H J ; Park, S W ; Seo, S S ; Park, SInternational journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.706-706 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
8 |
Material Type: Artigo
|
0374: Follow-Up Monitoring of Squamous Cell Carcinoma Antigen and Carcinoembryonic Antigen in Cervical Cancer Treated with Concurrent ChemoradiotherapyShin, K H ; Yoon, S M ; Kim, J ; Yoo, H J ; Park, S W ; Seo, S S ; Park, SInternational journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.706-707 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
9 |
Material Type: Artigo
|
0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loopXia, Caixia ; Shui, Liyan ; Lou, Guohua ; Ye, Bingjue ; Zhu, Wei ; Wang, Jing ; Wu, Shanshan ; Xu, Xiao ; Mao, Long ; Xu, Wanhong ; Chen, Zhi ; Liu, Yanning ; Zheng, MinScientific reports, 2017-06, Vol.7 (1), p.4396-9, Article 4396 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
10 |
Material Type: Artigo
|
06.03 Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapyWienke, J ; Visser, LL ; Kholosy, WM ; Keller, KM ; Barisa, M ; Munnings-Tomes, S ; Carlton, E ; Poon, E ; Rodriguez, A ; Bernardi, R ; van den Ham, F ; van Hooff, SR ; Langenberg, KPS ; Holstege, FCP ; Chesler, L ; Anderson, J ; Caron, HN ; Margaritis, T ; van Noesel, MM ; Molenaar, JJJournal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A2-A2 [Periódico revisado por pares]London: BMJ Publishing Group LtdTexto completo disponível |